Hpv malignant transformation. The role of HPV in the etiopathogenesis of inverted papilloma.
P Abstract Sinonasal inverted papilloma is a rare benign epithelial hpv malignant transformation.
Its three main clinical characteristics are the tendency of recurrence, the destructive ability of nearby structures and malignant transformation. The primary manifestations of this tumor include nasal obstruction, headaches, runny nose, hemorrhage and impaired sense of smell.
The diagnosis is based on the clinical and endoscopic examination completed by CT or MRI scans and biopsy of the lesion.
Human Papilloma Virus (HPV)
Allergies, chronic inflammation, nicotinism and viral infections hpv malignant transformation as HPV infection are considered possible causes of pathogenesis and potential risk factors for relapse and malignancy. The treatment for this condition is the complete removal of the tumor with disease-free margins.
Postoperative follow-up is essential for the early detection of recurrence or malignant transformation.
One of the most basic and important steps in managing these patients is to acknowledge the presence of the mentioned risk factors and avoid exposure. Due to the high risk of relapse, the follow-up must be aggressive and thorough and always include the endoscopic examination.
In our article, we wish to highlight the importance of the proper surgical intervention, but also the difference in the overall outcome of the patient ensured by the correct management of the risk factors, allowing us to prevent recurrence and malignant transformation.
Hpv malignant transformation - Oxiuri la copii an Papilloma malignant. Schneiderian papilloma malignant HPV is causing a variety of benign, borderline and malignant disorders, with common anogenital signs. The association of various types of treatment is still the preferred method to eradicate HPV infection. This paper offers information about possible systemic treatments of HPV infection, based on the documentation from the PubMed databaseincluding immunomodulatory drugs, antiviral medications, therapeutic HPV vaccines and papilloma malignant therapy.